National and Kapodistrian University of Athens
Ιντεγκρινο-εξαρτώμενη ρύθμιση κολλαγονασών (MMPs) από την αμυλοειδική β πρωτεΐνη: πιθανός ρόλος της κολλαγονάσης B (MMP-9) στον μεταβολισμό της πρόδρομης πρωτεΐνης του αμυλοειδούς (APP)
Abstract
dc:descriptionAlzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by the presence of brain amyloid plaques, composed mostly of amyloid beta peptides (Αβ40-42), generated by proteolytic processing of amyloid precursor protein (APP). Cleavage of APP by α-secretases within the Aβ sequence results in the secretion of a soluble N-terminal APP fragment (sAPPa) and generation of a membrane-bound COOH terminal fragment (CTF). This processing does not result in Aβ formation. However, cleavage by β- and γ-secretases generates Aβ peptides and an ectodomain derivative (sAPPβ). Two subclasses of the metalloproteinase family of proteases, matrix metalloproteinases (MMPs) and their close relatives a disintegrin and metalloprotease (ADAMs) have been implicated in receptor shedding including APP. MDC9, ADAM 10 and TACE, members of the ADAM family of proteases, have been shown to have a-secretase activity. However, the role of metalloproteinases in the pathogenesis of AD is not clear, even though several investigators reported that these enzymes might be involved in Aβ clearance. Elevated levels of MMPs in particular MMP-9 have been reported in the cortex and hippocampus of AD patients relative to control individuals. In the hippocampus of AD patients, increased immunoreactivity of the inactive form of MMP-9 was observed around the plaques, whereas, a very recent report stated that activated astrocytes surrounding amyloid plaques, showed enhanced expression of MMP-2 and MMP-9 in aged APP/presinilin 1 mice. Furthermore, active matrix metalloproteinase 9 (MMP-9) has been reported to degrade in vitro synthetic Aβ(1-40) at the α-secretase cleavage site between Lys 16-Leu 17 and amyloid beta fibrils. These observations have correlated increased expression especially of MMP-9, with AD. To address the mechanism of enhanced MMP-2 and MMP-9 secretion in the presence of Aβ we examined the possible role of integrins, since these receptors mediate at least in part the expression of MMPs. First we examined the effect of Aβ on MMP secretion in the human neuroblastoma cell line (SK-N-SH) as a neuronal cell model, providing evidence that neuronal cells as well as glial cells secrete increased levels of MMP-2 and MMP-9 in the presence of Aβ. Assays inhibiting the binding of these cells to solid-phase Aβ(1-40) were performed, in the presence of anti-integrin antibodies against the major integrins of these cells. These assays indicated that α₃β₁ and α₂β₁ integrin receptors mediated binding of SK-N-SH cells to Αβ(1-40). Additionally, using anti-a3, anti-β1 and anti-a2 monoclonal antibodies as ligands for the α₂β₁ and α₃β₁ integrins, lead to a vast increase of secreted MMPs especially MMP-9, indicating that α₃β₁ and α₂β₁ integrin receptors modulate the expression of these enzymes following cell binding to Aβ (1-40) substrate. To provide evidence regarding the possible role of MMP-9 in AD, we examined the role of MMP-9 on APP processing. We used MMP-9-transfected cells which over-express APP695 (HEK/APP695) to address the hypothesis that MMP-9, in addition to cleaving Aβ, also participates in processing intact, cell surface APP. Our experiments demonstrate that transfection-induced expression of MMP-9, or MMP-9 exogenously added to HEK/APP695 cells which normally secrete negligible amounts of this enzyme, markedly enhanced constitutive shedding of APP and decreased secretion of Aβ (1-40): APP immunoprecipitated on agarose G beads and exposed to exogenous activated MMP-9, released increased amounts of the soluble sAPPa fragment, indicating direct proteolytic cleavage of APP by this enzyme. Moreover, transfection-induced expression of human MMP-9 by HEK/APP695 cells (HEK/APP695/MMP-9) resulted in increased protein kinase C-stimulated secretion of sAPPa, suggesting that MMP-9 was involved in receptor-mediated sAPPa release. The observation that activation of protein kinase C with phorbol esters did not alter the levels of cellular APP, further suggests that increased levels of sAPPa were the result of increased MMP-9-mediated processing of APP. In several types of cultured cells inactive pro-MMP-9 co-exists with potential pro-MMP-9 activators. The mechanisms involved in activation of the secreted enzyme are not fully understood. It has been suggested that secreted pro-MMP-9 interacts with cell surface components which serve as docking molecules. Activation is then triggered by other proteases leading to proteolytic cleavage of the extracellular domain of the docking molecule and release (shedding) of this domain from the cell surface. According to this hypothesis, APP could be a candidate docking molecule for MMP-9, hence we examined whether APP associates with MMP-9. Immunoprecipitation and confocal microscopy experiments demonstrated that APP co-precipitated and co-localized with the latent (inactive) form of MMP-9 on the cell surface. Surface bound-latent, 92kDa-MMP-9 could be cleaved to form the active 88kDa-MMP-9 by intermediate activators, and enabled to shed cell surface APP. In conclusion, our data suggest a possible regulating mechanism according to which exposure of SK-N-SH cells to increased concentration of Aβ peptide results in increased expression of both MMP-2 and MMP-9. Up regulation of these enzymes is mediated at least in part via α₃β₁ and α₂β₁ integrin receptors. Association of latent MMP-9 with APP on the cell surface could trigger the activation of the latent MMP-9 to the active form by intermediate activators leading to proteolytic cleavage of the docking molecule (APP), in a manner similar to a secretase, precluding thus the formation of aggregating Aβ. Based on these findings we hypothesize that MMP-9 forms part of a neuroprotective, partly integrin-mediated shedding of APP.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Talamagas, Argyrios
- Ταλαμάγκας, Αργύριος
Subjects
dc:subject × 31- Νόσος Alzheimer
- Μεταλλοπρωτεάσες εξωκυττάριας ουσίας
- Ματριξίνες
- Ιντεγκρίνες
- Κυτταρικές σειρές
- Χημικά αντιδραστήρια
- Αντισώματα
- Κυτταροκαλλιέργειες
- Πειράματα κυτταρικής πρόσφυσης
- Απομόνωση πρωτεϊνών
- Ηλεκτροφόρηση πρωτεϊνών
- Ανοσοαποτύπωση
- Ανοσοκατακρήμνιση
- Ενζυμοσύνδετη ανοσοπροσροφητική μέτρηση
- Ανοσοφθορισμός
- Κυτταρομετρία ροής
- Κλωνοποίηση ανασυνδυασμένων πλασμιδίων
- Πυκνομετρική ανάλυση
- MMPs
- APP
- TIMPs
- PAGE
- MMP-9
- ELISA
- MMP-2
- TIMP-2
- TIMP-1
- Φυσικές Επιστήμες
- Βιολογία
- Natural Sciences
- Biological Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/22552